Metraipolis › archive › dc_35f31aef617b

Targeted α-therapy using astatine ( 211 At)-labeled PSMA1, 5, and 6: a preclinical evaluation as a novel compound — Europe PMC PMID:36344651

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/36344651
DOI
10.1007/s00259-[numero omesso]-z
License (as archived)
solo-consultazione
Archived
2026-11-01T06:33:00.722Z
SHA-256 of the archived text
905b49b65b52c8918db4318e5b8be28d089b71d32d9020feb2771d80f1b5f3e0
Stable URL of this page
https://metraipolis.com/documento/dc_35f31aef617b

How to cite

Targeted α-therapy using astatine ( 211 At)-labeled PSMA1, 5, and 6: a preclinical evaluation as a novel compound — Europe PMC PMID:36344651 — Europe PMC (en), https://europepmc.org/article/MED/36344651 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_35f31aef617b (Metraipolis archive dc_35f31aef617b, sha256 905b49b65b52c8918db4318e5b8be28d089b71d32d9020feb2771d80f1b5f3e0)
BibTeX
@misc{dc35f31aef617b,
  title = {Targeted α-therapy using astatine ( 211 At)-labeled PSMA1, 5, and 6: a preclinical evaluation as a novel compound — Europe PMC PMID:36344651},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/36344651},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_35f31aef617b; sha256 905b49b65b52c8918db4318e5b8be28d089b71d32d9020feb2771d80f1b5f3e0},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/36344651. Agents can read the archived copy with the MCP tool read_document.